Compositions and methods for treating fibrotic disorders

Details for Australian Patent Application No. 2006210848 (hide)

Owner Amgen Inc.

Inventors Fitzpatrick, David R.; Comeau, Michael R.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006210848

PCT Pub. Number WO2006/083947

Priority 60/649,287 01.02.05 US

Filing date 1 February 2006

Wipo publication date 10 August 2006

Acceptance publication date 22 October 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 39/17 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/083947 Priority application(s): WO2006/083947

22 October 2009 Application Accepted

  Published as AU-B-2006210848

18 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210863-Vaccine delivery compositions and methods of use

2006210847-Method and device for selective addition of a bioactive agent to a multiphase implant